How is IBD/steroid-responsive enteropathy diagnosed?

How is IBD/steroid-responsive enteropathy diagnosed?

• A. Exclusion of other causes + response to immunosuppression
• B. Biopsy alone
• C. Response to antibiotics
• D. Diet trial alone

Answer: (A)

The best approach hinges on recognizing that there isn’t a single test that proves IBD or steroid-responsive enteropathy. In practice, diagnosis is made by ruling out other causes of chronic GI signs and then confirming that immunosuppressive therapy yields improvement. This means thorough workup to exclude infections, parasitism, neoplasia, pancreatitis, and other inflammatory or metabolic diseases, followed by a therapeutic trial with immunosuppressants (typically corticosteroids) to see if the animal’s symptoms and signs improve. Histopathology from biopsies can support the diagnosis but isn’t definitive on its own, because similar inflammatory patterns can occur with other diseases. A response to antibiotics would point toward an antibiotic-responsive enteropathy rather than IBD, and a diet trial alone points toward a food-responsive enteropathy. Hence, the combination of excluding other causes and demonstrating a favorable response to immunosuppression best characterizes this diagnosis.

The best approach hinges on recognizing that there isn’t a single test that proves IBD or steroid-responsive enteropathy. In practice, diagnosis is made by ruling out other causes of chronic GI signs and then confirming that immunosuppressive therapy yields improvement. This means thorough workup to exclude infections, parasitism, neoplasia, pancreatitis, and other inflammatory or metabolic diseases, followed by a therapeutic trial with immunosuppressants (typically corticosteroids) to see if the animal’s symptoms and signs improve. Histopathology from biopsies can support the diagnosis but isn’t definitive on its own, because similar inflammatory patterns can occur with other diseases. A response to antibiotics would point toward an antibiotic-responsive enteropathy rather than IBD, and a diet trial alone points toward a food-responsive enteropathy. Hence, the combination of excluding other causes and demonstrating a favorable response to immunosuppression best characterizes this diagnosis.